Team

Robin Prasad, MD, MS, MBA

Managing Partner

Dr. Robin Prasad is a board-certified radiologist with fellowship training in MRI and Neuroradiology. He has over 17 years of experience as a radiologist and has worked in a variety of clinical environments. In 2010, Dr. Prasad co-founded Lexington Radiology Inc., and as Chairman, helped lead the transformation of a troubled department into the highest rated service line in the hospital.

Dr. Prasad earned a Bachelor of Science degree in mechanical engineering from the Massachusetts Institute of Technology where he placed 2nd in MIT’s mechanical engineering design competition. He completed his medical training and a Master of Science in biomedical engineering at McGill University. His Master’s thesis was the development of a computer simulation of the human respiratory system. He recently earned an MBA at the University of Pittsburgh. Dr. Prasad completed an internship at Tulane University, residency at New York University, and a fellowship at Thomas Jefferson University Hospital.

 

Dr. Prasad has a life-long passion for entrepreneurial endeavors. Over the past decade, he has become increasingly involved in real estate investment and early stage business development and investment. He has been a member of BlueTree Allied Angels for nearly a decade. He is also a member of the Pittsburgh Venture Capital Association and a member of the Pittsburgh South Side Chamber of Commerce. These affiliations have allowed him to assess hundreds of early stage companies. His prior experience investing in early stage companies has yielded profitable returns and been highly rewarding. On a personal note, Dr. Prasad enjoys time with his wife of 17 years and their two young children. His main hobby is playing the drums

Tom Deur, MD

Managing Partner

Dr. Tomislav Deur (Tom) is a board-certified radiologist currently working at UPMC Altoona. He has over 17 years of radiology experience working in various clinical settings ranging from urban and rural hospital settings to practicing teleradiology from Australia and Europe.

Dr. Deur attended an accelerated 7 year BA-MD program and has a Bachelor of Arts degree in Chemistry from Brooklyn College and a Medical Doctorate degree from the SUNY Health Science Center in Brooklyn. He was selected into the Phi Beta Kappa honor society as a junior college student and is a member of the Alpha Omega Alpha Honor Medical Society. He completed his internal medicine radiology internship at Staten Island University, and his radiology residency and interventional/vascular radiology fellowship at New York University.

Dr. Deur has a passion for entrepreneurship, and he recently received a Small Business Innovation Research Phase 1 (SBIR) grant for the development of a vascular access device for hemodialysis patients. This prestigious grant is awarded through the National Science Foundation to further research on technological innovations that may benefit society. Dr. Deur currently has multiple patent pending applications for vascular devices. He enjoys spending time with his wife and two children, and his hobbies include cycling and traveling.

Mike Thomas

Managing Partner

Mike was a Venture Capitalist at the Inova Health System Strategic Investments (ISI) in northern VA. He was one of three partners managing a $150MM strategic fund. With a 1.3x multiple on invested capital to date, Mike’s IRR stands at 33.9%. Prior to Inova, he was a serial healthcare technology CEO for over 20 years. Mike raised $125 million in capital
and drove shareholder returns that ranged from 4x to 80x, including one IPO and one acquisition.

 

Mike was most recently the founder and CEO of Appian Medical, a digital health firm that served the sleep apnea market. Previously, Mike was CEO of iSonea Ltd (ASX:ISN), a publicly traded global, mobile health app developer and medical device manufacturer in the respiratory disease market, where he increased the company’s market capitalization from $4MM to $250MM. Earlier in his career, Mike was President and CEO of Sleep Solutions, a VC-backed medical device manufacturer, EVP of Sales and Marketing for National Sleep Technologies (NST, acquired by GE Medical), and Vice President of Sales at Patient InfoSystems (NASDAQ: PATI).

 

Mike began his career in sales and marketing at Merck and GlaxoWellcome. He is currently a member of the Board of Directors for Tanzen Medical, Inc and is Chairman of the Board for international medical device innovator Bone Index Limited (Finland), a med device startup focused on diagnosis of osteoporosis. He is also a former board member of AdvaMed, the global medical device association. Mike graduated from Cornell University with a degree in
Microbiology.

Jerry Murray

Venture Partner

Jerry Murray is a highly respected, experienced healthcare CEO with more than 35 years of progressive experience in mergers and operational consolidations, physician network development and practice acquisition, service line management and growth. 

Jerry Murray was the former president at UPMC Altoona and UPMC Bedford Memorial hospitals. He previously served as president and CEO of Altoona Regional Health System prior to the merger with UPMC in July 2013.  Previously, Murray served as senior vice president/Clinical Services at Altoona Regional, and prior to that, held various leadership positions at Mercy/Bon Secours Holy Family Hospital for 19 years. 

 

He received his master’s degree in physiology at Temple University in Philadelphia and his bachelor’s degree in health/physical education from Indiana University of Pennsylvania. Murray serves on a variety of nonprofit and community organizations in Blair County. He is also a member of Our Lady of Victory.

Mark Weiss, MD

Venture Partner

Mark Weiss is a practicing board certified diagnostic radiologist with added qualifications in vascular and interventional radiology.  He was recently named a Fellow of the American College of Radiology (FACR) by the American College of Radiology (ACR).  

Dr. Weiss is a Co-Founder and Senior Consultant for Radiology Business Solutions. He has gained a reputation with hospital administrators and radiologists alike as an analytical, fair and objective consultant. As an advisor, mediator and mentor, Dr. Weiss helps build trust and communication between physicians and administrators. He excels at helping each party see the other’s position and find common ground to align interests.

Mark is a graduate of Michigan State University College of Human Medicine; completed his Residency at Michigan State University/University Affiliated Hospitals of Flint and Fellowship at Hammersmith Hospital in London, England.  

Venture Partners

Strategic Advisers

Paul Berger, MD

Adviser

  • Chairman, Partners in the Imaging Enterprise

  • Past founder and CEO, NightHawk Radiology Services

  • Led IPO of Nighthawk Radiology Services

  • Former President and CEO of MEMRAD Medical Group Inc.

  • Pediatric Neuro-Radiologist

Joe Marks, PhD

Adviser

  • Exec. Director, CMU Center for Machine Learning & Health

  • Expert in AI and human-computer interaction

  • 30 years of experience in applied computing

  • Experience includes healthcare industry innovation

  • Graduate and undergraduate degree from Harvard University

Wido Menhardt, PhD

Adviser

  • SVP Clinical Decision Making, Digital Health, Siemens Healthineers

  • Technology and Business Leadership positions with Philips, Kodak, Danaher, and Beckman Coulter

  • 30 years of experience in radiology software

  • PhD in Artificial Intelligence

  • Start-up experience in 3D Imaging, Image Guided Surgery, Cardiac Navigation, Natural Language
    Processing, and Computer
    Assisted Detection/Diagnosis

Catherine Mott, MBA, MS

Adviser

  • CEO/Founder, BlueTree Capital Group, BlueTree Allied Angels, and BlueTree Venture Fund

  • The BlueTree entities have invested $50MM+ in startups

  • Former Chairman of Angel Capital Association and Angel Resource Institute

  • Worked 17 years in senior management roles in corporate banking management

  • Holds multiple board seats and has won several awards in investment sector

Yvonne W. Lui, MD

Adviser

  • Associate Chair of AI, NYU Langone’s Dept. of Radiology

  • Associate Professor at NYU School of Medicine

  • Senior Editor of the American Journal of Neuroradiology

  • Leader of pioneering research in the study of brain injury

  • Former Section Chief, Neuroradiology at NYU Langone

Steven Martin

Adviser

  • CEO, Pond Tech, a company that profitably transforms CO2 into products

  • Former CTO of Pond Tech and Chief Scientist of Pond Biofuels Inc.

  • Has held multiple Director positions at the University of Toronto and George Brown College

  • Former Senior Scientist for EXFO Photonics Solutions

  • H.B.Sc in Chemical Physics, B.A.Sc in Mechanical Engineering, University of Toronto

Greg Rose, MD

Adviser

  • Founder and Former CEO of Rays Teleradiology

  • Former CEO of Envision Radiology

  • Practicing Diagnostic Radiologist for 15+ years

  • MRI Fellow at the Mayo Clinic, PhD Physics

  • 3 Technical Radiology Patents

Kelly Szejko

Adviser

  • President, Pittsburgh Venture Capital Association

  • Has generated over $750M in investment capital

  • Oversees annual 3 Rivers Venture Fair

  • Founder of Tikes, Inc., an association management company

  • Former accountant and corporate controller

To contact our team, please email info@boldbrainventures.com

To learn more about the Bold Brain Ventures investment fund, please register for an account (free of charge) and view our Private Placement Memorandum

REGULATION D 506(C) MANDATED LEGEND

Any historical performance data represents past performance. Past performance does not guarantee future results; Current performance may be different than the performance data presented; The Company is not required by law to follow any standard methodology when calculating and representing performance data; The performance of the Company may not be directly comparable to the performance of other private or registered funds or companies; The securities are being offered in reliance on an exemption from the registration requirements, and therefore are not required to comply with certain specific disclosure requirements; The Securities and Exchange Commission has not passed upon the merits of or approved the securities, the terms of the offering, or the accuracy of the materials.

  • Twitter Social Icon
  • LinkedIn Social Icon
  • mailchimp icon